Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

SkinPen® Precision ya bajo gestión directa en el Reino Unido e Irlanda
  • USA - čeština
  • USA - Pусский
  • USA - slovenčina
  • USA - English
  • USA - Polski
  • USA - Français
  • USA - Deutsch

Crown Laboratories

News provided by

Crown Laboratories, Inc.

Apr 12, 2021, 12:10 ET

Share this article

Share toX

Share this article

Share toX

DALLAS, 12 de abril de 2021 /PRNewswire/ -- Crown Aesthetics, una división de Crown Laboratories, Inc., se complace anunciar que SkinPen Precision, el primer dispositivo de microagujas aprobado por la FDA y el estándar de oro para la tecnología de remodelación de la piel, ahora tiene presencia directa en el Reino Unido e Irlanda.

La llegada al mercado de Crown Aesthetics (anteriormente conocida como Bellus Medical) es una importante inversión organizativa que confirma el compromiso de Crown con sus clientes y pacientes. Reconocida por su dedicación a la excelencia, la inversión de Crown garantiza el mejor nivel de servicio en su clase que los clientes y pacientes de SkinPen Precision esperan en todo el mundo.

"Al apoyar directamente a nuestros clientes de SkinPen, les ayudaremos a hacer crecer sus prácticas impulsando la demanda de los pacientes", dijo Andy Moulton, vicepresidente internacional de ventas de Crown Aesthetics. "Ahora recibirán el nivel superior de capacitación, educación y servicio al cliente que se merecen".

Lanzado en 2013 y respaldado por más de 90 estudios de validación *, SkinPen Precision es un dispositivo de remodelación de la piel superior diseñado y fabricado en EE. UU. El uso previsto de SkinPen para CE incluye un tratamiento para mejorar la apariencia de las cicatrices del acné facial en adultos de 22 años o más y para mejorar la apariencia de líneas finas y arrugas en la cara y el cuello. SkinPen también trata las afecciones de la pigmentación (discromía), incluidos el melasma, el vitiligo y las pecas solares (manchas solares/de la edad). SkinPen Precision es un dispositivo médico de Clase IIa que funciona creando microlesiones controladas para estimular la respuesta natural de curación de heridas del cuerpo y remodelar el tejido cicatricial. El galardonado SkinPen tiene un perfil de seguridad superior y se ha demostrado clínicamente que es eficaz en todos los tipos de piel de Fitzpatrick. Los pacientes experimentan un daño celular mínimo y poco o ningún tiempo de inactividad.

SKINPEN® PRECISION A SU SERVICIO:  

Horas de apertura: Lunes - Viernes 9.00 am – 17.00 pm

Pedidos o preguntas

  • Clientes del Reino Unido: [email protected]
  • Clientes de Irlanda: [email protected]

Contactos de Crown Aesthetics  

Servicio al cliente (Ballyclare, Irlanda del Norte)

Lisa Scott, Customer Success Specialist
[email protected] 
Reino Unido: 028 9334 4411
Irlanda: +44 28 9334 4411

Marketing / Comunicaciones

Reena Sandhu, directora de Aesthetics Marketing Operations, Reino Unido/Irlanda
[email protected],  07365 145 207

Consultas generales - [email protected]

Médica/Clínica - [email protected]

Sitios web de SkinPen Precision:

  • Reino Unido e Irlanda: www.skinpen.uk
  • Internacional: www.skinpen.com/international

Acerca de Crown
Crown, una compañía de cuidado de la piel global privada y totalmente integrada, se dedica a desarrollar y ofrecer una diversa cartera de productos de estética, belleza y cuidado de la piel que mejoran la calidad de vida de sus clientes.  Una compañía innovadora centrada en la ciencia dermatológica para la vida, la firme búsqueda de Crown de la excelencia terapéutica y resultados del paciente mejorados es lo que la han llevado a convertirse en líder en Dermatología y Estética. Crown se ha incluido en la Inc. 5000 Fastest Growing Privately Held Companies List durante siete años y ha expandido su distribución a más de 38 países. Para más información sobre Crown o sus productos, visite www.crownlaboratories.com.

Acerca de Crown Aesthetics
Crown Aesthetics, la principal compañía de estética médica, se dedica a ayudar a las prácticas estéticas líderes de todo el mundo a hacer crecer sus negocios. Hacemos esto ofreciendo resultados drásticos en rejuvenecimiento y restauración. Nuestras innovaciones no invasivas– SkinPen®, el primer dispositivo de micro-inyecciones aprobado por la FDA; el protocolo post-micro-inyecciones Skinfuse®; y el sistema de plasma rico en plaquetas (PRP) ProGen™ Advantage – actúan como productos "de puerta de enlace" que atraen nuevos clientes a la práctica. Con sede en Dallas, Texas, Crown Aesthetics establece estándares de la industria en eficacia, seguridad e innovación. Como resultado, nuestros clientes ofrecen consistentemente el mejor cuidado estético en el negocio. Para más información, visite www.crownaesthetics.com.

* Datos de Crown Aesthetics en archivo.

Para indicaciones en EE.UU., resumen completo del ensayo clínico e información de seguridad importante, incluida la contraindicación y cómo utilizar el dispositivo de microagujas SkinPen Precision, visite www.skinpen.com.

Logo - https://mma.prnewswire.com/media/1457834/Crown_Logo.jpg 

Related Links

https://crownaesthetics.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Косметика BIOJUVE® удостоена награды «Лучший косметический бренд года» на AMWC 2025 в Монако

Косметика BIOJUVE® удостоена награды «Лучший косметический бренд года» на AMWC 2025 в Монако

Компания Revance с гордостью сообщает, что BIOJUVE, инновационное средство для ухода за микробиомом кожи от Crown Aesthetics, было удостоено...

Marka BIOJUVE® wyróżniona tytułem Najlepszego Kosmetyku Roku na targach AMWC 2025 w Monako

Marka BIOJUVE® wyróżniona tytułem Najlepszego Kosmetyku Roku na targach AMWC 2025 w Monako

Firma Revance z nieukrywaną dumą informuje, że marka BIOJUVE, seria innowacyjnych produktów pielęgnacyjnych, wspierających mikrobiom skóry od Crown...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Corporate Expansion

Corporate Expansion

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.